MIRA INFORM REPORT

 

 

Report Date :

04.06.2014

 

IDENTIFICATION DETAILS

 

Name :

NATULAB LABORATÓRIO S/A

 

 

Registered Office :

Rua H,2 Galpão Iii - Bairro Urbis II, 44574-150 - Santo Antonio DE Jesus/BA

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

30.03.1998

 

 

Legal Form :

Privately Held Corporation

 

 

Line of Business :

Manufacturer of pharmaceuticals

 

 

No of Employees :

780

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1.000.000,00

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow But Correct

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

 

D

 


 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, and a rapidly expanding middle class, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth in 2011-13. Unemployment is at historic lows and Brazil's traditionally high level of income inequality has declined for each of the last 14 years. Brazil's historically high interest rates have made it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchange markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint.

 

Source : CIA

 

 


COMPANY NAME

 

NATULAB LABORATÓRIO S/A

 

ADDRESSES

 

MAIN ADDRESS:

RUA H,2 GALPÃO III - BAIRRO URBIS II

ZIP CODE/CITY:

44574-150 - SANTO ANTONIO DE JESUS/BA

 

 

PHONE:

75 3311-5579

E-MAIL:

catiamota@gruponatulab.com.br

WEB SITE:

www.natulab.com.br

 

BRANCHES:

 

NOT AVAILABLE.

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACURE OF PHARMACEUTICALS.

 

LEGAL FORM:

PRIVATELY HELD CORPORATION

 

 

INCORPORATION DATE:

30/03/1998

REGISTER DATE:

30/03/1998

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

02.456.955/0001-83

STATE REGISTER:

48.969.842

 

 

SHARE CAPITAL:

R$ 94.697.988,00

 

 

BOARD OF DIRECTORS:

 

 

 

MARCONI TRINDADE SAMPAIO

PRESIDENT DIRECTOR

CLAUDIO DA SILVA NEVES

FINANCIAL DIRECTOR

ROGER BATISTA ASSIS VIANA

ADMINISTRATIVE DIRECTOR

NORBERTO WHITAKER SOBRAL JANNUZZI

COMMERCIAL DIRECTOR

 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

ARRIBA PARTICIPAÇÕES S/A

55,47%

SONIA LAURA TRINDADE SAMPAIO

9,12%

OTHERS

35,41%

 

 

 

AFFILIATES / SUBSIDIARIES:

 

 

 

GRANJAS CANAA LTDA

 

BRAZILIAN FIREWORKS INDUSTRIAL LTDA ME

 

FAMILY EMPREENDIMENTOS E PARTICIPAÇÕES  LTDA

 

MILTON DE OLIVEIRA SAMPAIO

 

NATULAB TECN E SERV ESPECIALIZADOS LTDA

 

TRANSAÚDE GESTÃO DE SERVIÇOS LTDA

 

DOTE GESTÃO DE EVENTOS LTDA ME

 

CONTACT ASSESSORIA - PREST SERV DE CALL CENTER SÃO PAULO LTD

 

CAU CENTRAL DE ATENDIMENTO A USUÁRIOS LTDA

 

SEMPREUTIL COM E DISTRIBUIÇÃO LTDA EPP

 

CARVÃO ITÚ LTDA

 

MARFIM PARTICIPAÇÕES PATRIMONIAIS LTDA

 

R. PIRES IND E COM DE ALIMENTOS LTDA

 

PRAIA DO SOL EMPREEND CONS E PARTICIPAÇÕES LTDA

 

AUXILIUM ENG CONS ADM PRISIONAL LTDA

 

PALADIUM EMPREEND E PARTICIPAÇÕES LTDA ME

 

DIRIGIR CLÍNICA MEDICA S/C LTDA

 

SALIMAR EMPREENDIMENTOS MARINHOS LTDA

 

PROMOEVENT PROMOÇÕES E EVENTOS LTDA

 

CIVILIZAÇÃO COMERCIO E SERVIÇOS LTDA

 

PETNOR IND E COMERCIO DE EMBALAGENS LTDA

 

MILTON DE OLIVEIRA SAMPAIO JUNIOR ME

 

A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR

 

DIRECTORS HAS THE FOLLOWING UNCONFIRMED HOLDINGS:

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON MARCH 30, 1998 AS NATULAB LAORATÓRIO LTDA. TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON JUNE 30, 2004 IT ALTERED TO NATULAB LABORATORIO FARMACÊUTICO LTDA. ON DECEMBER 12, 2007 IT ADOPTED THE ABOVE-MENTIONED NAME.

 

TRADE NAME: "NATULAB LABORATÓRIO FARMACÊUTICO".

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

1

FEDERAL LAWSUIT

20/09/13

20ª VARA DE SALVADOR/BA

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2013, 31/12/2012 AND 31/12/2011.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2013

31/12/2012

31/12/2011

 

 

 

 

CASH AND CASH EQUIVALENTS

2.736

2.085

1.065

INVESTMENTS

 

17

221

CLIENTS

35.029

27.911

16.992

INVENTORY

22.066

12.538

7.643

RECOVERABLE TAXES

1.174

1.041

488

OTHER

2.440

1.888

644

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

63.445

45.480

27.053

 

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

NOTES RECEIVABLE

451

407

237

CREDIT WITH RELTD COMPANIES

3.011

1.079

1.434

OTHER CREDITS

590

590

135

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

4.052

2.076

1.806

 

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

44.718

23.507

16.473

INTANGIBLE

16.558

23.538

19.933

INVESTMENTS

19.894

14.506

6.637

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

81.170

61.551

43.043

 

==============

==============

===============

TOTAL ASSETS

148.667

109.107

71.902

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2013

31/12/2012

31/12/2011

 

 

 

 

SUPPLIERS

13.586

6.534

3.525

LOANS AND FINANCING

17.536

17.607

10.282

SOCIAL / LABOR OBLIGATIONS

3.035

2.409

1.469

TRIBUTARY OBLIGATIONS

1.917

2.528

2.481

INCOME TAX/SOCIAL CONTRIBUTION

136

1.132

165

LABOR PROVISIONS

4.508

3.102

1.872

PROFIT SHARING

421

402

511

OTHER

752

122

168

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

41.891

33.836

20.473

 

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

11.212

14.382

9.485

TRIBUTARY OBLIGATIONS

12.607

9.674

8.863

PROFIT SHARING

1.200

870

814

DIVIDENDS PAYABLE

 

2.672

785

DEFERRED TAXES

570

570

384

DEBT WITH RELATED COMPANIES

15

332

1.340

ACCOUNTS PAYABLE

462

418

458

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

26.066

28.918

22.129

 

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

90.240

30.460

15.962

TREASURY SHARES

-300

-300

-1.373

OTHER COMPREHENSIVE INCOME

816

816

816

OTHER

-12.822

-1.172

 

PROFIT RESERVES

2.776

16.549

13.895

 

----------------

----------------

----------------

TOTAL NET EQUITY

80.710

46.353

29.300

 

==============

===============

===============

TOTAL LIABILITIES

148.667

109.107

71.902

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2013, 31/12/2012 AND 31/12/2011.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

 

 

31/12/2013

31/12/2012

31/12/2011

 

 

 

 

NET SALES

111.179

87.301

50.814

(-) COST OF SOLD GOODS

50.954

40.477

24.283

 

----------------

----------------

----------------

GROSS PROFIT

60.225

46.824

26.531

OPERATING REVENUE (EXPENSE)

-51.221

-22.174

-14.015

FINANCIAL REVENUE(EXPENSE)

-7.954

-5.886

-6.236

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

1.050

18.764

6.280

CONTRIBUTION/INCOME TAX

 

-1.153

-165

 

----------------

----------------

----------------

NET PROFIT (LOSS)

1.050

17.611

6.115

 

 

RATIOS:

31/12/2013

31/12/2012

31/12/2011

 

QUICK RATIO

,99

 

,97

 

,95

 

CURRENT RATIO

1,51

 

1,34

 

1,32

 

ACCOUNTS RECEIVABLE TURNOVER

3,17

TIMES

3,13

TIMES

2,99

TIMES

DAYS' SALES IN RECEIVABLES

113,42

DAYS

115,10

DAYS

120,38

DAYS

INVENTORY TURNOVER

2,31

TIMES

3,23

TIMES

3,18

TIMES

ACCOUNTS PAYABLE PERIOD

95,99

DAYS

58,11

DAYS

52,26

DAYS

RETURN ON ASSETS

,75

TIMES

,80

TIMES

,71

TIMES

SALES TURNOVER ON NET EQUITY

1,38

TIMES

1,88

TIMES

1,73

TIMES

NET WORTH TIE-UP

,55

 

,51

 

,56

 

INDEBTEDNESS

,84

 

1,35

 

1,45

 

EQUITY RATIO

54,29

%

42,48

%

40,75

%

WORKING CAPITAL RATIO

51,45

%

34,41

%

32,14

%

GENERAL SOLVENCY

2,19

 

1,74

 

1,69

 

RETURN ON NET EQUITY

1,30

%

37,99

%

20,87

%

RETURN ON SALES (PROFIT MARGIN)

,94

%

20,17

%

12,03

%

GROSS PROFIT MARGIN

54,17

%

53,64

%

52,21

%

OPERATIONAL RESULT

,94

%

21,49

%

12,36

%

SALES TURNOVER ON LIABILITIES

2,65

TIMES

2,58

TIMES

2,48

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,22

 - OFFICIAL RATE ON 29/05/2014

US$ 1,00 = R$ 2,34

 - OFFICIAL RATE ON 31/12/2013

US$ 1,00 = R$ 2,04

 - OFFICIAL RATE ON 31/12/2012

US$ 1,00 = R$ 1,87

 - OFFICIAL RATE ON 31/12/2011

 

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS

 

THE FIGURES AVAILABLE SHOW A FAIR FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS HIGH BUT IT HAS GOOD CURRENT RATIO AND POSITIVE WORKING CAPITAL, CONSIDERED SUFFICIENT TO COVER THE SHORT TERM DEBTS. IT ALSO SHOWS GROWING SALES AND MADE PROFIT.

 

 

REAL ESTATE:

 

OWNED PREMISES ARE VALUED AT R$ 639.000,00

 

 

VEHICLES:

 

NOT AVAILABLE

 

 

MACHINES:

 

NOT AVAILABLE

 

 

INSURANCE

 

NOT AVAILABLE

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO DO BRASIL S/A

0563-0 / 75 3631-4333

 

BANCO BRADESCO S/A

1425-7 / 71 3355-6453

 

BANCO MERCANTIL S/A

0094 / 71 4009-7500

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

 

MANUFACURE OF PHARMACEUTICALS.

 

 

IMPORT AND EXPORT:

 

 

IMPORTS FROM:

 

NOT AVAILABLE.

 

 

EXPORTS TO:

 

NOT AVAILABLE.

 

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

 

MEDCHAP DISTRIBUIDORA DE MEDICAMENTOS CHAPECÓ LTDA

 

 

MS FARMA COMERCIAL LTDA

 

 

MSR FARMA COMERCIAL LTDA

 

 

RAIMUNDO FLORINDO DE CASTRO

 

 

 

 

STAFF:

 

THE COMPANY HAS: 780 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1998. SO FAR IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

PHONE:

AB PLAST PLÁSTICOS LTDA

 

47 3451-9103

ADRIANO & ANDRE LUIZ DE CASTRO ARAUJO LTDA ME

 

 

ADRIVAN

 

11 6163-6210

ALCAN PACKAGING DO BRASIL LTDA

 

 

ANASTÁCIO

 

11 3578-3671

CAMURI COM EMB DOCES LTDA

 

75 3602-9686

CIA INDUSTRIAL DE VIDROS - CIV

 

81 3272-4486

COMAPEL

 

75 3631-8000

CONSERLI

 

11 6953-7623

COSMOQUIMICA

 

11 9772-4937

EMBAHIA IND COM DE PLASTICOS LTDA

 

71  594-9661

ETICOLA

 

75 3623-1888

HEAT LABEL

 

11 2441-0210

INDUKERN

 

11 3689-7666

INJETPLAST

 

82  522-3122

LABSYNTH

 

11 4072-6103

STARPACK

 

11 2875-5712

VEDAT

 

11 2133-1212

 

 

PAYMENT HISTORY:

 

13 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 1.155.033,00

 

AMOUNT OF INVOICES PAID: 206

TOTAL OF PROMPT PAYMENTS: 87,9%

TOTAL OF DELAYED PAYMENTS: 12,1%

 

HIGHEST INVOICE: R$ 50.872,00

HIGHEST CREDIT: R$ 50.872,00

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

AN INITIAL CREDIT LIMIT OF USD 1.000.000,00 MAY BE CONSIDERED.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 59.21

UK Pound

1

Rs. 99.16

Euro

1

Rs. 80.56

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

DPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.